Biohaven Ltd.

BHVN NYSE SEC CIK 1935979
Follow Biohaven Ltd. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$129.3M +25.5% vs same quarter last year
EPS, diluted −$0.86 +47.6% vs same quarter last year
Operating cash flow −$106.9M +26.7% vs same quarter last year
Operating income −$126.4M +25.4% vs same quarter last year
Net income by quarter
−$186.8M
−$221.7M
−$198.1M
−$173.4M
−$145.6M
−$130.5M
−$137.3M
−$129.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
−$1B−$750M−$500M−$250M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$738.8M
FY24−$846.4M
FY23−$408.2M
FY22−$570.3M
FY21−$213.8M
FY20−$118.7M
FY19-
Free cash flowOperating cash flow minus capital expenditure
−$800M−$600M−$400M−$200M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$610.2M
FY24−$586.5M
FY23−$334.8M
FY22−$303.8M
FY21−$146.8M
FY20−$77.1M
FY19-